Global and India Newborn Screening for SMA and SCID Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global and India Newborn Screening for SMA and SCID Market Report & Forecast 2024-2034
Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.
Market Analysis and InsightsGlobal and India Newborn Screening for SMA and SCID Market
This report focuses on global and India Newborn Screening for SMA and SCID market, also covers the segmentation data of other regions in regional level and county level.
The global Newborn Screening for SMA and SCID revenue was US$ 129.2 million in 2024 and is forecast to a readjusted size of US$ 288 million by 2034 with a CAGR of 11.5% during the review period (2024-2034).
Global key players of newborn screening for SMA and SCID include Perkinelmer, Thermo Fisher, ImmunoIVD, Labsystems Diagnostics, etc. The top three players hold a share over 85%. North America is the largest market, has a share about 60%, followed by Europe, with share 25%.
Global Newborn Screening for SMA and SCID Scope and Market Size
Newborn Screening for SMA and SCID market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Newborn Screening for SMA and SCID market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For India market, this report focuses on the Newborn Screening for SMA and SCID market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in India.
Perkinelmer
Thermo Fisher
ImmunoIVD
Labsystems Diagnostics
Segment by Type
Instruments
Kits
Software
SCID Screening
SMA Screening
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Newborn Screening for SMA and SCID definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Newborn Screening for SMA and SCID companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Newborn Screening for SMA and SCID in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Newborn Screening for SMA and SCID revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Market Analysis and InsightsGlobal and India Newborn Screening for SMA and SCID Market
This report focuses on global and India Newborn Screening for SMA and SCID market, also covers the segmentation data of other regions in regional level and county level.
The global Newborn Screening for SMA and SCID revenue was US$ 129.2 million in 2024 and is forecast to a readjusted size of US$ 288 million by 2034 with a CAGR of 11.5% during the review period (2024-2034).
Global key players of newborn screening for SMA and SCID include Perkinelmer, Thermo Fisher, ImmunoIVD, Labsystems Diagnostics, etc. The top three players hold a share over 85%. North America is the largest market, has a share about 60%, followed by Europe, with share 25%.
Global Newborn Screening for SMA and SCID Scope and Market Size
Newborn Screening for SMA and SCID market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Newborn Screening for SMA and SCID market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For India market, this report focuses on the Newborn Screening for SMA and SCID market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in India.
By Company
Perkinelmer
Thermo Fisher
ImmunoIVD
Labsystems Diagnostics
Segment by Type
Instruments
Kits
Software
Segment by Application
SCID Screening
SMA Screening
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Newborn Screening for SMA and SCID definition, global market size, India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Newborn Screening for SMA and SCID companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Newborn Screening for SMA and SCID in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Newborn Screening for SMA and SCID revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions